Arthritis Res. 2002;4 Suppl 3:S3-15. Epub 2002 May 9.

Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.

Source

INSERM U 25, Hôpital Necker, Paris, France. bach@necker.fr

Abstract

The nonobese diabetic (NOD) mouse is a well-recognised animal model of spontaneous autoimmune insulin-dependent diabetes mellitus. The disease is T-cell mediated, involving both CD4 and CD8 cells. Its progress is controlled by a variety of regulatory T cells. An unprecedented number of immunological treatments have been assessed in this mouse strain. This chapter systematically reviews most of these therapeutic manoeuvres, discussing them in the context of their significance with regard to the underlying mechanisms and the potential clinical applications. The contrast between the surprisingly high rate of success found for a multitude of treatments (more than 160) administered early in the natural history of the disease and the few treatments active at a late stage is discussed in depth. Most of the concepts and strategies derived from this model apply to other autoimmune diseases, for which no such diversified data are available.

PMID:: 12110118; [PubMed - indexed for MEDLINE]
PMCID: PMC3240130

Free PMC Article

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Diabetes intervention therapy. [J Diabetes Complications. 1993]
Review Diabetes intervention therapy.
Maclaren NK. J Diabetes Complications. 1993 Apr-Jun; 7(2):151-6.
Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. [Proc Natl Acad Sci U S A. 1992]
Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
Maki T, Ichikawa T, Blanco R, Porter J. Proc Natl Acad Sci U S A. 1992 Apr 15; 89(8):3434-8.
Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. [J Exp Med. 1997]
Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.
Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P. J Exp Med. 1997 Nov 17; 186(10):1663-76.
Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. [Eur J Immunol. 1992]
Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M. Eur J Immunol. 1992 Sep; 22(9):2387-93.
Review Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy. [Immunobiology. 2009]
Review Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T, Welzen-Coppens JM, Leenen PJ, Drexhage HA, Versnel MA. Immunobiology. 2009; 214(9-10):791-9. Epub 2009 Jul 22.

See reviews... See all...

Cited by 2 PubMed Central articles

Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies. [Immunology. 2008]
Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies.
Hall TR, Bogdani M, Leboeuf RC, Kirk EA, Maziarz M, Banga JP, Oak S, Pennington CA, Hampe CS. Immunology. 2008 Apr; 123(4):547-54. Epub 2007 Nov 14.
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. [J Clin Invest. 2004]
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.
Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA. J Clin Invest. 2004 Oct; 114(7):979-87.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.
Arthritis Res. 2002 ;4 Suppl 3:S3-15. Epub 2002 May 9 .

PubMed
Epidemiologic studies for osteoarthritis: new versus conventional study design a...
Epidemiologic studies for osteoarthritis: new versus conventional study design approaches.
Rheum Dis Clin North Am. 2004 Nov ;30(4):783-97, vii.

PubMed
Estrogen deficiency and bone loss: an inflammatory tale.
Estrogen deficiency and bone loss: an inflammatory tale.
J Clin Invest. 2006 May ;116(5):1186-94.

PubMed
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthe...
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.
J Exp Med. 2000 Aug 21 ;192(4):565-70.

PubMed
Cyclophosphamide versus placebo in scleroderma lung disease.
Cyclophosphamide versus placebo in scleroderma lung disease.
N Engl J Med. 2006 Jun 22 ;354(25):2655-66.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: